0000899243-20-025431.txt : 20200916 0000899243-20-025431.hdr.sgml : 20200916 20200916204033 ACCESSION NUMBER: 0000899243-20-025431 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200916 FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VV Manager II, LLC CENTRAL INDEX KEY: 0001824569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 201179907 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6176489100 MAIL ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vida Ventures II, LLC CENTRAL INDEX KEY: 0001776851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 201179908 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET, SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-254-9492 MAIL ADDRESS: STREET 1: 40 BROAD STREET, SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VIDA VENTURES II-A, LLC CENTRAL INDEX KEY: 0001781930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 201179909 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET, SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-254-9492 MAIL ADDRESS: STREET 1: 40 BROAD STREET, SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-09-16 0 0001818794 Dyne Therapeutics, Inc. DYN 0001824569 VV Manager II, LLC 40 BROAD STREET, SUITE 201 BOSTON MA 02109 0 0 1 0 0001776851 Vida Ventures II, LLC 40 BROAD STREET, SUITE 201 BOSTON MA 02109 0 0 1 0 0001781930 VIDA VENTURES II-A, LLC 40 BROAD STREET, SUITE 201 BOSTON MA 02109 0 0 1 0 Series B Preferred Stock Common Stock 2087130 I See footnote Series B Preferred Stock Common Stock 57916 I See footnote The Series B Preferred Stock is convertible into common stock on a 3.3169-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. The shares are held directly by Vida Ventures II, LLC ("Vida II"). VV Manager II, LLC ("VV Manager II") is the manager of Vida II. Arie Belldegrun, Fred Cohen, and Leonard Potter are the members of the management committee of VV Manager II (the "Management Committee") and Stefan Vitorovic, Arjun Goyal, Helen Kim, Rajul Jain, and Joshua Kazam are the members of the investment committee of VV Manager II (the "Investment Committee"). (Continued from footnote 2) Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein. The shares are held directly by Vida Ventures II-A, LLC ("Vida II-A"). VV Manager II is the manager of Vida II-A. Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II-A. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II-A and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein. /s/ Vida Ventures II, LLC By: VV Manager II, LLC, its Manager, By: /s/ Stefan Vitorovic, its Managing Director 2020-09-16 /s/ Vida Ventures II-A, LLC By: VV Manager II, LLC, its Manager, By: /s/ Stefan Vitorovic, its Managing Director 2020-09-16 /s/ VV Manager II, LLC, By: /s/ Stefan Vitorovic, its Managing Director 2020-09-16